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Summary: This study was conducted to compare the two techniques head to head in regards to efficacy and adverse events when used as first-line endovascular treatment for revascularization of patients with acute ischemic stroke and large vessel occlusion. The Contact Aspiration vs Stent Retriever for Successful Revascularization (ASTER) study was a randomized, open-label, blinded end-point clinical trial conducted in eight comprehensive stroke centers in France from October 2015 to October 2016. Patients who presented with acute ischemic stroke and a large vessel occlusion in the anterior circulation within 6 hours of symptom onset were included. Patients were randomly assigned to firstline contact aspiration (n ¼ 192) or first-line stent retriever (n ¼ 189) immediately prior to mechanical thrombectomy in a 1:1 fashion. The primary outcome was the proportion of patients with successful revascularization defined as a modified Thrombolysis in Cerebral Infarction score of 2b or 3 at the end of all endovascular procedures. Secondary outcomes included degree of disability assessed by overall distribution of the modified Rankin Scale (mRS) score at 90 days, change in National Institutes of Health Stroke Scale (NIHSS) score at 24 hours, all-cause mortality at 90 days, and procedure-related serious adverse events. Among 381 patients randomized (mean age, 69.9 years; 174 women [45.7%]), 363 (95.3%) completed the trial. Median time from symptom onset to arterial puncture was 227 minutes (interquartile range, 180-280 minutes). For the primary outcome, the proportion of patients with successful revascularization was 85.4% (n ¼ 164) in the contact aspiration group vs 83.1% (n ¼ 157) in the stent retriever group (odds ratio, 1.20; 95% confidence interval [CI], 0.68-2.10; P ¼ 0.53; risk difference, 2.4%; 95% CI, À5.4% to 9.7%). Rescue treatment was needed in slightly more patients in the contact aspiration group (32.8% vs 23.8%, ns). For the clinical efficacy outcomes (change in NIHSS score at 24 hours, mRS score at 90 days) and adverse events, there were no significant differences between groups. Symptomatic intracranial hemorrhage occurred in 10 patients (5.3%) in the contact aspiration group and 12 patients (6.5%) in the stent retriever group (NS).
Comments: Vascular surgeons are faced with patient who experience stroke with a distal embolus that might be retrieved. The technical aspects mature with time and this study demonstrates that either aspiration or stent retriever thrombectomy can be used with similar efficacy but superiority was the study design and that was not proven. Prior to this study, stent retriever was the technique used in the original randomized controlled trials to demonstrate the benefits of embolus removal.
Repeated Measurements of Serum Concentrations of TNF-alpha, Interleukin-6, and Interleukin-10 in the Evaluation of Internal Carotid Artery Stenosis Progression Przemyslaw P, Lasek-Bal A. Atherosclerosis 2017;263:97-103.
Conclusions: Long-term trends in serum concentrations of IL-6 and IL-10 in patients with ICA stenosis helps predict stenosis progression and unfavorable changes in plaque morphology.
Summary:
The inflammatory process appears key in the development, progression and destabilization of atherosclerotic plaques. The aim of this study was to assess the importance of double-checked measurements of tumor necrosis factor alpha (TNFa), interleukin-6 (IL-6) and interleukin-10 (Il-10) serum levels in patients with internal carotid artery (ICA) stenosis to determine the dynamics of changes in the stenosis degree and ultrasound determined plaque morphology. This prospective study included 65 patients (20 women and 45 men), mean age 66.3 6 7.8 years, with symptomatic (39 individuals) or asymptomatic (26) atherosclerotic internal carotid artery stenosis above 50% confirmed by duplex imaging. All patients were treated with antiplatelets, statins, antihypertensives, and antidiabetic agents as appropriate. The carotid artery ultrasounds were performed during qualification and every 3 months to identify any progression of stenosis degree and changes in plaque morphology. Serum concentrations of TNF-alpha, IL-6 and IL-10 were measured during qualification and at six months. Calculations considered cytokine concentrations and their indices determined as relative differences of cytokine levels assessed in the first compared to the second tests. Patients with increasing degree of ICA stenosis had higher indices of IL-6 (0.77 vs 0.40; P ¼ .046) and IL-10 (1.28 vs 0.13; P ¼.02) than patients without any increase in the degree of stenosis. A statistically significant probability of unfavorable dynamics of atherosclerotic plaque morphology (potentially associated with plaque instability) was found for the indices of IL-6 (odds ratio [OR] Comments: Serum indices of inflammation may become one factor that will influence the decision to operate in patients with vascular occlusive disease. Much work yet needs to be done to determine the appropriate inflammatory serum markers to measure that allows a better interventional algorithm outside of what patient symptoms and imaging can already provide. Without such critical analysis, serum markers will be an additional cost without improved quality care. Conclusions: There was no significant difference in mortality of symptomatic superior mesenteric artery (SMA) dissection patients without accompanying proof of bowel ischemia or aneurysm between interventional treatment and conservative treatment. An additional treatment is needed in a minority of patients receiving conservative treatment, however, more frequently than in those receiving endovascular treatment.
Outcomes of Treatment Strategies for Isolated
Summary: Isolated spontaneous SMA dissection without aortic dissection is being increasingly recognized. This study aimed to evaluate the latest clinical characteristics and optimal treatment. The authors searched the Cochrane Library, MEDLINE, and ClinicalTrial.gov databases through December 31, 2016, using the words: ''superior mesenteric artery'' and ''dissection.'' for articles presenting the treatment and outcomes of isolated SMA dissection published in English. Patient characteristics, treatments, follow-up, and prognoses were collected. Additionally, the authors compared mortality rates and assessed the need for additional interventions when comparing treatment strategies in symptomatic patients without accompanying proof of bowel ischemia or aneurysm. Fiftyone pertinent articles were identified consisting of 721 patients. Acute abdominal pain was observed in all 617 symptomatic patients and (31) 5% of the symptomatic patients had bowel ischemia, peritonitis, necrosis, aneurysmal rupture or aneurysm > 2 cm. The patients with complications were treated by endovascular (9) or surgical (22) means. The remaining 586 symptomatic patients were initial treated with conservative management (n ¼ 481; 82.1%), endovascular treatment (14.3%), catheterdirected infusion of medication (2.1%), and surgery (1.5%). Anticoagulants were more commonly used (57%) in conservative treatment than antiplatelet therapy (30%). Additional treatments were performed because of the recurrence or continuance of abdominal pain, aneurysmal change, and bowel ischemia. Additional treatment was needed in 18.1% of patients receiving conservative treatment and 2.4% of patients receiving endovascular treatment (P ¼ .0003) and generally during the initial episode. Mortality was not significantly different between each treatment strategy (P ¼ .92) with an overall rate of 0.69%. Asymptomatic patients Review and commentary of key articles
